Pneumonia, Bacterial Clinical Trials
93 clinical trials for Pneumonia, Bacterial across international registries, including 9 currently recruiting participants. Compare status, phase, eligibility criteria and locations.
- " Study of the Benefit of Nebulized Amikacin in the Treatment of Gram-negative Bacillus Pneumonia Acquired During Mechanical Ventilation in Patients Receiving Extracorporeal Membrane Veno-arterial Oxygenation " — RECRUITING · PHASE2
- A Trial to Evaluate the Safety and Reactogenicity of an Investigational Pneumococcal Vaccine in Toddlers 12 to 15 Months of Age Receiving a Single Booster Dose — RECRUITING · PHASE1
- MP101 in Adults With Acute Pseudomonas Aeruginosa Pneumonia — RECRUITING · PHASE1
- Combination vs. Monotherapy for Stenotrophomonas Maltophilia Infections — RECRUITING
- Different Methods of Aerosolized Polymyxin B Inhalation for Treating Carbapenem-Resistant Gram-Negative Bacterial Pneumonia. — RECRUITING
- Novel Tools to Improve Management of Paediatric Community-Acquired Pneumonia - ToolCAP — RECRUITING · NA
- Rapid De-escalation of Anti-MRSA Therapy Guided by S. Aureus Nares Screening in Case of Pneumonia — RECRUITING · NA
- Study of Leukocyte Immunophenotype and the Lipid Transport System as Predictive Biomarkers of Severe Bacterial Infections — RECRUITING
- Fosfomycin I.v. for Treatment of Severely Infected Patients — RECRUITING
- Clinical Impact of a Machine Learning Decision Support System for Empirical Antibiotic Therapy — NOT_YET_RECRUITING · NA
- Comparative Study of Adherence to Antibiotic Therapy Among Pediatric Patients: Hospital Emergency Department vs. Primary Care Center — NOT_YET_RECRUITING
- A Trial to Evaluate the Safety and Reactogenicity of an Investigational Pneumococcal Vaccine in Infants Receiving 3-dose Primary Dosing Series Followed by a Booster Dose at 12 to 15 Months of Age — NOT_YET_RECRUITING · PHASE1
- A Trial to Evaluate the Safety and Immune Response of an Investigational Pneumococcal Vaccine in Adults 50 To 64 Years of Age — COMPLETED · PHASE1
- Trial to Evaluate Safety and Immune Response of an Investigational Pneumococcal Vaccine in Adults Aged 50 To 64 Years — ACTIVE_NOT_RECRUITING · PHASE1
- Impact of BioFire FilmArray Pneumonia Panel vs Routine Diagnostics on Antimicrobial Outcomes (DOOR-MAT) — NOT_YET_RECRUITING · NA
- MASTERMIND-Pneumonia Study (Also Known as Pneumonia Direct Pilot) — COMPLETED
- Systematic Search for Primary Immunodeficiency in Adults With Infections — COMPLETED · NA
- Using Probability of Community-Acquired Pneumonia to Tailor Antimicrobials Among Inpatients — COMPLETED · NA
- Impact of a Strategy Based on Bacterial DNA Detection to Optimize Antibiotics in Patients With Hospital-acquired Pneumonia — COMPLETED · NA
- Artificial Intelligence-Based Evaluation of Chest X-Rays in Ventilator-Associated Pneumonia — COMPLETED
- Derivation and Validation of the Risk Evaluation Score for Pneumonia Involving Resistant Entities (RESPIRE) — COMPLETED
- Blinded Efficacy and Safety Study of CAL02 IV Plus SOC in Subjects With Severe Community-Acquired Bacterial Pneumonia — ACTIVE_NOT_RECRUITING · PHASE2
- Discharge Stewardship in Children's Hospitals — ACTIVE_NOT_RECRUITING · NA
- A Phase 2 Study to Evaluate the Safety, Tolerability, and Immune Response of AFX3772 Vaccine in Healthy Infants — COMPLETED · PHASE2
- Urine Pneumococcal Antigen Project — NOT_YET_RECRUITING
- Urease Breath Test for Rapid Characterization of Pneumonia — COMPLETED
- Comparison Between the Progostic Value of the Procalcitonin and the Platelet/Total Leukocytic Count Ratio in Sepsis — COMPLETED
- Antimicrobial Therapeutic Drug Monitoring During Lung Transplant Perioperative Phase — NOT_YET_RECRUITING
- PROcalcitonin Impact on Antibiotic Reduction, adverSe Events and AVoidable healthcarE Costs (ProSAVE): A RCT — COMPLETED · NA
- Imipenem/Cilastatin/Relebactam Pharmacokinetics, Safety, and Outcomes in Adults and Adolescents With Cystic Fibrosis — TERMINATED · PHASE4
- Cefiderocol Pharmacokinetics in Adult Patients With Cystic Fibrosis — COMPLETED · PHASE4
- Pediatric Helmet CPAP Pilot Study — TERMINATED · NA
- Effectiveness of Oral Management Strategies on Improving Oral Frailty and Oral Bacteria — COMPLETED · NA
- CPAP Therapy Through a Helmet or a Full Face Mask in Patients With Acute Hypoxemic Respiratory Failure: Cross-over Study — COMPLETED · NA
- Application of the Recommendations of the SPLIF (French Society of Infectious Pathology) in a Geriatric Population on the Duration of Treatment for Bacterial Pneumonia — COMPLETED
- Diagnostic Accuracy of Pocket-size Lung Ultrasound in Pneumonia Etiology and Complications in Hospitalized Children — OTHER · NA
- Eravacycline Combination Therapy for MRAB — OTHER
- Defining Antibiotic Treatment Duration for Ventilator - Associated Lung Infection — COMPLETED · PHASE3
- Enhancing Electronic Health Systems to Decrease the Burden of Colon Cancer, Lung Cancer, Obesity, Vaccine-Preventable Illness, and LivER Cancer — COMPLETED · NA
- A Single Ascending Dose Study in Adults (Stage 1) and Single Ascending Dose-Finding Study (Stage 2) in Elderly Subjects With ASP3772, A Pneumococcal Vaccine — COMPLETED · PHASE1
- Prevalence and Serotype of Streptococcus Pneumoniae Hospitalized Adult With Community-Acquired Pneumonia — COMPLETED
- Search for Biomarkers of Infection and Inflammation in Patients With Acute Stroke. — OTHER
- CTTI Risk Factors for HABP/VABP Study — COMPLETED
- Aerosolized Colistin to Mechanical Ventilated Patients With Pneumonia — COMPLETED · NA
- Efficacy and Safety of Nemonoxacin vs Levofloxacin in Adult Patients With Community-Acquired Pneumonia — COMPLETED · PHASE3
- Pneumonia in the ImmunoCompromised - Use of the Karius Test for the Detection of Undiagnosed Pathogens — COMPLETED
- Diagnostic Accuracy of Infection Biomarkers in the Initial Investigation of Patients With Suspected Pneumonia — COMPLETED
- The Effect of a Point-of-care Sputum Specimen Assay at the Emergency Department for Patients Suspected of Pneumonia — COMPLETED · NA
- Avoidable Hospitalizations/ Emergency Department Visits- Systematic Review and Meta-synthesis of Qualitative Research — OTHER
- Diagnostic and Prognostic Biomarkers for Childhood Bacterial Pneumonia — COMPLETED
Refine this search